The medicaments used to prevent, destroy, repel, or mitigate external or internal parasites in animals are referred as parasiticides.
Factors such as the rising demand for animal food products, increasing investments for government organizations and private players, growing concerns over zoonotic diseases, worldwide regulations for the prevention of spread of diseases, growth in the companion animals market, and increasing veterinary healthcare expenditures are expected to drive the market growth during the forecast period.
The animal parasiticides market was valued at USD 6.99 billion in 2014 and is expected to grow at a CAGR of 5.7% during the forecast period of 2015 to 2020 to reach to USD 9.76 billion by 2020.
The emerging markets such as Asia Pacific provide significant investment opportunities for market players to grow their animal parasiticides business.
The base year considered for the study is 2014, and the forecast has been provided for the period between 2015 and 2020.
Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=258895412
- Animal Parasiticides Manufacturers
- Animal Parasiticides Distributors
- Animal Health Research & Development (R&D) Companies
- Government Associations
- Research and consulting firms
- Venture Capitalists and Investors
The key players operating in the animal parasiticides market are Bayer AG (Germany), Boehringer Ingelheim (Germany), Ceva Sante Animale (France), Eli Lilly and Company (US), Merck and Co., Inc. (US), Zoetis, Inc. (U.S.), Sanofi (France), Virbac (France), Vetoquinol S.A. (France), Perrigo Company PLC (Ireland), Dechra Pharmaceuticals Plc (UK), and Huvepharma (Bulgaria).